Master gene allows breast cancer growth, invasion
February 13th, 2010 - 12:16 pm ICT by ANIWashington, Feb 13 (ANI): Baylor College of Medicine researchers and collaborators have claimed that the master gene called SRC-3 (steroid receptor coactivator 3) not only enhances estrogen-dependent growth of cancer cells by activating and encouraging the transcription of a genetic message into a protein, it also sends a signal to the cell membrane to promote cell motility or movement - a key element of cancer spread or metastasis.
The study has been published in the current issue of the journal Molecular Cell.
The finding not only uncovers a new activity for SRC-3 at the cell’s periphery, it also clears up a mystery about how the message that tells a cell to invade gets from the epidermal growth factor receptor (EGFR) to the activating enzyme called FAK (focal adhesion kinase) found on the cell’s membrane, said Dr. Bert O’Malley, chair of molecular and cellular biology at BCM and the report’s senior author.
“Two-thirds of breast cancers over express the gene SRC-3,” said O’Malley, who is the 2008 National Medal of Science recipient. “The work represented in this paper shows that a coactivator gene (SRC-3) can produce an alternative form of its coactivator protein - a shorter form that is missing the part of the protein that keeps it in the nucleus. With that portion (called an exon) gone, it leaves the nucleus and goes into the cytoplasm (or general area of the cell) and travels to the membrane,” he said.
“At the membrane, the enzyme PAK1 (p21-activted kinase 1) phosphorylates (attaches a phosphate molecule that activates the coactivator) SRC-3, allowing it to function at the membrane,” said O’Malley, responsible for identifying the first receptor coactivator and advancing the field in general. (ANI)
- Critical tuning dial for controlling body energy identified - Jan 05, 2011
- Adopting 'synthetic lethality' could boost molecularly targeted cancer therapy - Sep 22, 2010
- Molecular switch that helps pancreatic cancer beat drugs identified - Jan 29, 2010
- Now, prostate cancer can be inhibited without disturbing body processes - Aug 10, 2010
- Aging-related protein holds breast cancer clues - Jan 28, 2011
- Gene that regulates blood sugar levels identified - Nov 28, 2008
- Link between obesity, insulin resistance paves way for safer diabetes drugs - Jul 22, 2010
- New ways for heart treatment - Mar 11, 2010
- Scientists discover key missing link in signaling pathway for plant steroid hormones - Sep 09, 2009
- Ultraviolet light 'helps skin cancer cells survive, proliferate' - Dec 08, 2010
- New personalized therapy to 'fool cancer cells into killing themselves' - Mar 01, 2011
- Scientists discover potential new drug therapy for kidney diseases - Apr 27, 2011
- Scientists discover protein that arrests cancer-spreading enzyme - Jan 04, 2011
- New treatment strategy effective for certain lung cancers - Mar 11, 2011
- India-US team finds new therapy for pancreatic cancer - Dec 30, 2008
Tags: baylor college of medicine, breast cancer, breast cancers, cancer cells, cancer growth, cell motility, college of medicine, dependent growth, egfr, epidermal growth factor, epidermal growth factor receptor, genetic message, growth factor receptor, malley chair, master gene, molecular and cellular biology, national medal of science, o malley, shorter form, steroid receptor